Genmab — Oktober 2019
-
Uden at have noge som helt lægefaglig indsigt, så læser jeg at Sanofi selv har droppet et fase 2-studio, det fremgår ikke, at det skulle være blevet underkendt! det kan jo have mange grunde? Selv om Isatuximab har samme virkningsmekanismer som Darzalex, så har Genmab jo ikke brugt Darzalex i den kombination som det her er beskrevet, sammen med Libtayo og i forsøg mod prostatakræft og lungekræft, så er det overhovedet sammenligneligt?jeg spørger bare i håb om at blive klogere.
-
Legolas23: Checkmate358 har lukket dara-cohorten. https://www.clinicaltrials.gov/ct2/show/NCT02488759?term=checkmate358&draw=2&rank=1 Checkmate142 har måske en chance for date først i 2020. https://www.clinicaltrials.gov/ct2/show/NCT02060188?term=checkmate142&draw=2&rank=1 Det rene dara-nivo hat stoppet rekruttering. Årsag uvis. https://www.clinicaltrials.gov/ct2/show/NCT03098550?term=daratumumab+nivolumab&draw=2&rank=2
-
-
Det har været oppe før
https://medwatch.dk/secure/Medicinal___Biotek/article10899921.ece -
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind